In an mTOR-driven HCC mouse model, tumor cells also increased arginine import and reduced its conversion to polyamines, driving oncogenic metabolism via the arginine-binding factor RNA-binding motif protein 39 (RBM39). This evidence concerns the gene MTOR and hepatocellular carcinoma.